Lincocin Forte S

Introduction

Company name: Pfizer Limited

Address: Ramsgate Road

Sandwich

Kent CT13 9NJ

Telephone: 0845 300 8034 (Out of hours: 01304 616161)

Fax: 01737 332521

Email: UKVetLine@pfizer.com

Website: www.only4vets.co.uk

Presentation

Intramammary infusion: lactating cow.

Each 10 ml syringe contains lincomycin (as lincomycin hydrochloride) 330 mg and neomycin (as neomycin sulphate) 100 mg.

Uses

For the treatment of mastitis in lactating cattle. The product is effective against Staphylococcus species (both penicillinase and non-penicillinase producers) including Staphylococcus aureus, Streptococcus species including Streptococcus agalactiae, Streptococcus dysgalactiae and Streptococcus uberis, and coliform bacteria including Escherichia coli.

Dosage and administration

Dosage

Infuse one syringe (10 ml. product) into each affected quarter. Repeat this treatment immediately after each of the next two 12 hourly milkings, to give a total of three infusions per infected quarter.

Administration

By intramammary infusion only, taking aseptic precautions. The syringe must only be used once.

Where necessary, wash teats or whole udder thoroughly with warm water containing a suitable dairy disinfectant and dry them thoroughly. Milk out the udder completely. Disinfect teat end with a pad of alcohol or other suitable disinfectant. Use a separate pad for each teat. Remove cap from plastic tip. Choose the desired insertion length (full or partial) and insert the tip into the teat canal. Push plunger to dispense entire contents and massage the quarter to distribute the product into the milk cistern. Following infusion, it is advisable to dip all teats in an approved teat dip.

Contra-indications, warnings, etc

Withdrawal periods

Milk

Milk for human consumption may only be taken from 84 hours after the last treatment.

Meat

Animals must not be slaughtered for human consumption during treatment.

Treated animals may be slaughtered for human consumption only after 3 days following the last treatment.

Operator warning

Avoid contact with the solution. Wash hands and any exposed skin immediately after use.

This product should not be used concomitantly with macrolides e.g. erythromycin, because lincomycin and the macrolides antagonise each other at the site of action, the 50S ribosomal sub-unit.

For animal treatment only.

Any unused product or waste material should be disposed of in accordance with national requirements.

Pharmaceutical precautions

Do not store above 25°C. Protect from freezing. Protect from light.

Keep out of reach of children.

Legal category

POM-V

Packaging Quantities

24 × 10ml plastic syringes.

Further information

Nil.

Marketing authorisation number

Vm 00057/4249.